Last reviewed · How we verify

Two doses of JE vaccine

Novartis · Phase 2 active Biologic

Two doses of JE vaccine is a Biologic drug developed by Novartis. It is currently in Phase 2 development.

At a glance

Generic nameTwo doses of JE vaccine
SponsorNovartis
ModalityBiologic
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Two doses of JE vaccine

What is Two doses of JE vaccine?

Two doses of JE vaccine is a Biologic drug developed by Novartis.

Who makes Two doses of JE vaccine?

Two doses of JE vaccine is developed by Novartis (see full Novartis pipeline at /company/novartis).

What development phase is Two doses of JE vaccine in?

Two doses of JE vaccine is in Phase 2.

Related